Abstract
In a phase I/II trial, patients with locally advanced rectal cancer received preoperative radiotherapy (RT) and concurrent with 5-fluorouracil (5-FU) and gefitinib. Results were promising. To elucidate the molecular and biological effects, we replicated the schedule in the LoVo human colorectal adenocarcinoma cell line.
Lingua originale | English |
---|---|
pagine (da-a) | 31-41 |
Numero di pagine | 11 |
Rivista | International Journal of Colorectal Disease |
Volume | 29 |
DOI | |
Stato di pubblicazione | Pubblicato - 2014 |
Keywords
- Antineoplastic Combined Chemotherapy Protocols
- Cell Line, Tumor
- Chemoradiotherapy
- Colorectal Neoplasms
- Combined Modality Therapy
- Fluorouracil
- Humans
- Quinazolines
- Real-Time Polymerase Chain Reaction